New Transcriptomic Clock Predicts Biological Age; Experts Recommend Key Biomarkers for Longevity
Scientists have developed a new transcriptomic clock that predicts biological age and mortality using gene activity patterns conserved across species. Longevity experts also recommend tracking specific biomarkers like fasting glucose, ApoB, and hs-CRP with optimal ranges to monitor health proactively. Regular biomarker testing from mid-30s onwards is encouraged for early detection of age-related changes.
Researchers have developed a new transcriptomic clock based on gene activity that accurately predicts biological age and mortality risk across species. The tool analyzes RNA molecules that translate genes into proteins to determine which genes are turned on and off, providing a signature of aging that is more accessible and informative than existing epigenetic clocks.
The new clock was validated using more than 11,000 samples from four mammals: mice, rats, macaques, and humans. It found that genes associated with healthy cell division and wound repair act as signs of slower molecular aging, while genes linked to cell death and inflammation mark faster aging. With human blood samples, the clock could predict time to death as well as the best epigenetic clocks and picked up known contributors to aging, such as chronic disease.
A key innovation was comparing aging processes between different species and body parts. The genetic signs of aging were surprisingly conserved across all four species and multiple cell types, including muscle and blood cells. The researchers believe the tool could be used to test the effects of different interventions, such as lifestyle changes or drugs, on biological aging without lengthy trials.
Beyond research tools, longevity experts emphasize the importance of tracking specific biomarkers for optimal health. Standard laboratory reference ranges are based on population averages that include unhealthy individuals, leading some experts to advocate for tighter optimal ranges reflecting peak function.
For metabolic health, experts recommend tracking fasting glucose, with an optimal range of 70 to 80 mg/dL, and fasting insulin, which should ideally be 2 to 5 μIU/mL at most. Hemoglobin A1C, which reflects average blood sugar over about 100 days, should be kept under 5%. A cholesterol risk ratio, calculated by dividing total cholesterol by HDL cholesterol, is also a practical marker of cardiovascular risk.
Beyond blood sugar and lipids, other significant biomarkers include ApoB, which represents the number of atherogenic particles that can damage arteries and is strongly linked to cardiovascular disease, and high-sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation that is a core driver of many age-related diseases. Cardiorespiratory fitness testing, particularly VO2 max, is highlighted as a powerful systemic predictor of longevity. Hormones such as free testosterone are also important, with optimal levels for men suggested as 180 to 250 pg/mL and for women at least 6 pg/mL.
Experts recommend a thorough biomarker assessment from one's mid-30s onwards, or earlier with a strong family history of chronic disease. The data from these tests can inform personalized interventions in nutrition, training, and medical protocols. As one longevity expert notes, "genetics load the gun, but lifestyle often pulls the trigger," and biomarker testing can empower proactive health management.